Abbott Laboratories (ABT) cash: $8.5B
Abbott Laboratories held $8.5B in cash and cash equivalents on Dec 31, 2025, up 11.9% from $7.6B a year earlier.
From Abbott Laboratories's filings with the SEC · Read the filing · ABT stock page
Abbott Laboratories cash by year
#75 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $8.5B | +12% |
| Dec 31, 2024 | $7.6B | +10% |
| Dec 31, 2023 | $6.9B | -30% |
| Dec 31, 2022 | $9.9B | +1% |
| Dec 31, 2021 | $9.8B | – |
Cash of similar companies
Companies in the same industry as Abbott Laboratories, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Merck | $14.6B | Dec 31, 2025 |
| Bristol Myers Squibb | $10.2B | Dec 31, 2025 |
| Abbott Laboratories | $8.5B | Dec 31, 2025 |
| Eli Lilly | $7.3B | Dec 31, 2025 |
| AbbVie | $5.2B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $5.1B | Dec 31, 2025 |
| BeOne Medicines | $4.5B | Dec 31, 2025 |
Questions and answers
What is Abbott Laboratories's cash?
Abbott Laboratories held $8.5B in cash and cash equivalents on Dec 31, 2025, up 11.9% from $7.6B a year earlier.
Numbers as reported in Abbott Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology